AR242590A1 - Glycoprotein modified by oxidation and reduction, inhibiting the ribosomes, method for its production and immunotoxins contaning said glycoprotein - Google Patents

Glycoprotein modified by oxidation and reduction, inhibiting the ribosomes, method for its production and immunotoxins contaning said glycoprotein

Info

Publication number
AR242590A1
AR242590A1 AR86306244A AR30624486A AR242590A1 AR 242590 A1 AR242590 A1 AR 242590A1 AR 86306244 A AR86306244 A AR 86306244A AR 30624486 A AR30624486 A AR 30624486A AR 242590 A1 AR242590 A1 AR 242590A1
Authority
AR
Argentina
Prior art keywords
glycoprotein
contaning
immunotoxins
ribosomes
inhibiting
Prior art date
Application number
AR86306244A
Other languages
Spanish (es)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of AR242590A1 publication Critical patent/AR242590A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A61K47/6827—Ricin A
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR86306244A 1985-12-20 1986-12-19 Glycoprotein modified by oxidation and reduction, inhibiting the ribosomes, method for its production and immunotoxins contaning said glycoprotein AR242590A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518982A FR2591895B1 (en) 1985-12-20 1985-12-20 LONG-LASTING IN VIVO IMMUNOTOXINS HAVING MODIFIED RICIN A CHAIN ON ITS POLYSACCHARIDE PATTERNS

Publications (1)

Publication Number Publication Date
AR242590A1 true AR242590A1 (en) 1993-04-30

Family

ID=9326039

Family Applications (1)

Application Number Title Priority Date Filing Date
AR86306244A AR242590A1 (en) 1985-12-20 1986-12-19 Glycoprotein modified by oxidation and reduction, inhibiting the ribosomes, method for its production and immunotoxins contaning said glycoprotein

Country Status (3)

Country Link
AR (1) AR242590A1 (en)
FR (1) FR2591895B1 (en)
ZA (1) ZA869573B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218460A (en) * 1985-11-29 1989-07-27 Univ Melbourne Ricin-antibody conjugate
DE4106389A1 (en) * 1991-02-28 1992-09-03 Behringwerke Ag FUSION PROTEINS FOR PRODRUG ACTIVATION, THEIR PRODUCTION AND USE
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
JPS5843926A (en) * 1981-09-08 1983-03-14 Suntory Ltd Selective carcinostatic agent
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates

Also Published As

Publication number Publication date
FR2591895B1 (en) 1988-08-26
ZA869573B (en) 1987-08-26
FR2591895A1 (en) 1987-06-26

Similar Documents

Publication Publication Date Title
AR242186A1 (en) Process for the production of 2,2,6,6,-tetraalkyl 4 piperidylamines
DE3664489D1 (en) Wear-resistant, sintered iron alloy and process for producing the same
AR242590A1 (en) Glycoprotein modified by oxidation and reduction, inhibiting the ribosomes, method for its production and immunotoxins contaning said glycoprotein
GB8620236D0 (en) Inert gas production
CS326686A2 (en) Zasobnik pro tycovite predmety, zejmena cigarety
GB2185493B (en) Metal production
DE3375978D1 (en) Shaped iron catalytic compound, its production and its use
GR3001236T3 (en) Glycoproteins modified by oxidation followed by reduction, which inhibit ribosomes, production process and immunotoxines containing such a glycoprotein
EP0172697A3 (en) Octahydro-oxazoloû4,5-g¨quinolines
OA08376A (en) 3,7-disubstituted-3-cephem compounds and processes for production of the same.
EP0216585A3 (en) 2,6,7-trisubstituted-3-methylenebicyclo û3.3.0¨octanes and process for production thereof
GB2184108B (en) Gallium production
GB8428332D0 (en) Mineshaft closures
IE852757L (en) Diastereoselective reduction process.
HUT40634A (en) Process for producing 4-hydroxy-benzisothiazol-3/2h/-one-1,1-dioxide
GB8717488D0 (en) Steel production
PL251271A1 (en) Multi-stage cyclohexane oxidation method
CS782785A1 (en) Dekontaminacni vana, zejmena pro dekontamimaci pohonu regulacnich organu jaderneho reaktoru
CS80185A1 (en) Polyuretanovy valcek, najmae pre tepovace kobercovpolyuretanovy valcek,najma pre tepovace kobercov
CS964485A1 (en) Zpusob snizovani fluktuace tlaku vzduchu v okoli rotujiciho telesa, napr. drevoobrabeciho nastroje
CS1045584A1 (en) Hmoty,zejmena pro lite bezesve podlahy
GB8410030D0 (en) Poly-1-substituted-cyclohexa-1,3-dienes
GB8404495D0 (en) Purifying transition metals
CS393486A1 (en) Zariadenie pre privod tlakovej kvapaliny do pracovnej komory trecieho uzaveru diferencialu, hlavne pre polnohospodarske traktory
CS747985A1 (en) Zarizeni k plneni zasobniku prirezy, zejmena trubek pro vyrobu chladicu